Giovanni Frisoni

Reframing the way we think about Alzheimer’s disease

Revising the amyloid hypothesis in Alzheimer’s disease: the probabilistic model

Blood-based biomarkers for Alzheimer’s disease screening

Ethical considerations of biomarker use in prodromal Alzheimer’s disease

The landscape of biomarkers for the management of Alzheimer’s disease

Task force from Geneva: Roadmap for biomarker validation in Alzheimer’s disease